Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Reshma Ramracheya

Reshma Ramracheya

Oxford Centre for Diabetes, Endocrinology & Metabolism University of Oxford UK

Amy Articolo

Amy Articolo

Vice President of Obesity Treatment Foundation USA

Edita Stokić

Edita Stokić

Edita Stokić Clinical Center of Vojvodina Serbia

Mathias A. Fobi

Mathias A. Fobi

International Federation for Surgery of Obesity and Metabolic Disorders (IFSO) USA

Hidekatsu Yanai

Hidekatsu Yanai

National Center for Global Health and Medicine Kohnodai Hospital Japan

Cliodhna Foley Nolan

Cliodhna Foley Nolan

Director of Human Health & Nutrition, Safefood Ireland

Hiro Yoshida

Hiro Yoshida

Harvard Medical School USA

Dr. Kaiser Raja

Dr. Kaiser Raja

Aster Liver Care UAE

Liver Cancer 2019

About Conference

About Conference                                                      


            ME Conference has the immense pleasure in organising “INTERNATIONAL METABOLIC DISEASES AND LIVER CANCER CONFERENCE ’’ during 27-28 of May in Istanbul. This conference is an open platform for Researchers, Aspiring students, Directors, Professors, Scientists, Academicians and Young researchers of life science department to present their diligent work in front of prominent personalities of the same field. The thoughts and work of the scholastic individuals can be displayed in the shape of verbal presentations, poster presentations and video presentations who are interested to gain global appreciation and to add betterment to human lives from their work. This conference provides wider knowledge in liver cancer and metabolic diseases thereby providing futuristic approaches to treat them in the near future.

Why to attend?

                                        “THE ONLY SOURCE OF KNOWLEDGE IS EXPERIENCE”

                “INTERNATIONAL METABOLIC DISEASES AND LIVER CANCER CONFERENCE ’’ is organized in order to bring light and hope to the dark sides of human liver cancer and irregular human metabolic diseases which are prevailing worldwide. This conference is beneficial on all sides as it gives exposure in an international way for people who attend and experience for people who present their work in front of people expertized in the field of Hepatology and Human metabolism.

Target Audience


                Clinical Research Associates

                Diabetes Educators


                Genetic Counsellor

                Healthcare Professionals


                Medical Oncologists

                Metabolic Professionals

                Medicinal Professionals




                Radiation Oncologists

                Research, Healthcare Scientists

                Surgical Oncologists

Why Istanbul, Turkey?

Istanbul is one of the world’s best places for any international event or conferences & a growing knowledge hub. Istanbul is additionally very positioned on the International Congress and Convention Centre’s city rankings for gatherings in every on-going year. Istanbul emerged as a global city and business hub of the Middle East. With all its treasure and pleasure Istanbul also concentrates more on the research work. As per the statistics the people in Istanbul suffer from cancer and it is one of reasons for the increase in death rate. There are also associations which work on managing the healthcare of the children and adults from any metabolic disorders and liver cancer. Istanbul will be a phenomenal destination to conduct LIVER 2019 and to bring out the rays of hope in treating Liver Cancer and Metabolic Disorders globally.


Scientific Sessions

Track1.Metabolic Diseases and Liver Cancer

Metabolic disease normally occurs in human body due to the alteration in the biochemical pathways and this is normally because of an autosomal recessive gene. This disruption in the normal metabolism leads to weight loss,jaundice, injury and dullness which finally indicates the presence of diseases like Diabetes Mellitus, Obesity, Gaucher’ s disease in the individual. In some cases irregular metabolic mechanism leads to liver cancer with cirrhosis being its backbone causative factor. Liver cancer is the sixth leading cancer worldwide with increasing mortality rate year by year.

Track2.Mechanism of Development and Progression

Metabolic disorders can either be innate or acute depending on the lifestyle of the person or by his/her genetic makeup. Liver cancer has four stages and at most cases they are identified at the final stage which is chronic and the result is death. The tumor initially develops at a particular region and then the tumor cells starts spreading through the blood and even forms tumor near liver which leads to malfunctioning of entire digestive system.

Track3. Inflammation, Epidemiology and Immunology

Inflammation in Hepatocellular carcinoma is hepatic injury and concurrent regeneration leading to tissue to rupture and damage. The tumor cells once settled down will start invading and migrates towards every end of the liver leading to apoptosis of the tissue. Cytokines and Chemokines play an important role in the mechanism of inflammation. According to global reports 42,200 people(30,610 Men, 11610 Women)are diagnosed and 30,200 people (20450 Men, 9660 Women) will die due to liver cancer.

Track4.Clinical Hepatocellular Carcinoma

The molecular targets of interest have expanded from angiogenesis to cancer cell-directed oncogenic signalling pathways for advanced HCC treatment .The feasibility of combining locoregional therapies and targeted agents, and the use of novel agents after curative treatments are currently under active investigation. Finally, the therapeutic strategy has shifted from monotherapy to combination targeted therapy.

Track5.Genetics and Epigenetics Of Liver Cancer

Considering certain cases liver cancer occurs due to genetic inheritance. Due to recessive genes, the human body will not fight against the antigens as they are unable to recognise and produce antibodies against the antigens. Whole genome analysis technique is used to find the genomic aberrations; DNA hypo methylation promotes a diverse range of Liver cancers.

Track6.Stem Cell Treatment

Stem cell treatment is the most noteworthy way to reduce the risk of Liver cancer. The self-renewal property of Bone marrow cells helps in differentiating normal adult stem cells into hepatocytes. This treatment can be done only when the metabolism is clearly understood. The treatment process involves the transplantation of Stem Cells and thereby monitoring the process with biomarkers which increases the efficacy of the Treatment. AFP-L3, Glypican-3, Cytokeratin 19 are notable biomarkers in Stem Cell Treatment of Liver Cancer.

Track7.Artificial Intelligence in Treating Hepatocellular Carcinoma

The neural network (NN) or fuzzy neural network (FNN) are used to diagnosis disease which are a kind of multi-dimensional nonlinear function, some markers may contain un-useful information for disease diagnosis and it decreases the accuracy of disease diagnosis ,To get rid of those un useful substances, microarray is used to increase accuracy. The benefits of machine learning and enormous information has made a difference in bringing Artificial Intelligence to the bleeding edge of healthcare and life science and is set to alter how industry analyses and treats tumour infections .

Track8.Drug Therapy and Development of Novel Drugs

According to Food and Drug Administration (FDA), Conserved domain Database(CDD), there a few characterized therapies for liver cancer like Radiation Therapy, Targeted Therapy, Chemotherapy and Immunotherapy. From researchers note it is reported that targeted therapy is a way better approach than standard chemotherapy. Sorafenib is one of the best Targeted drug that controls the growth of proteins stimulating cancer cells. Regorafenib is one of the additional dug in blocking the proteins helping the growth of tumour cells. Liver cancer Organoids are used in developing new drugs in treatment of liver cancer.

Track9. Pediatric Metabolic Disorders

Metabolic disorders in children are more because of genetic inheritance. There are endless sorts of metabolic clutters more up to date that keep popping all over the globe with deadly complications. Common symptoms among all metabolic disorders are lethargy, abdominal pain, delay in development and weight loss. DNA testing and Genetic Counselling are done to identify and diagnose metabolic disorders.

Track10.Diabetic Exposure and Liver Cancer

On basis with the statistical reports, it is framed that Type 2 Diabetes and liver Cancer goes hand in hand with the mechanism and complications. The risk of liver cancer is higher in people with Type 2 Diabetes than people with Type 1 Diabetes. An advance conceivable natural instrument for the affiliation between diabetes and liver cancer is that up to 80% of individuals with type 2 diabetes are thought to have non-alcoholic fatty liver illness which increments hazard of non-alcoholic steato-hepatitis, cirrhosis and consequent Hepatocellular Carcinoma(HCC).

Track11.Metabolic Reactions and Nutrition

Nutrition is the amount of Carbohydrates, Proteins, Vitamins, Minerals and fat components that we intake regularly. There is an irregularity in the mechanism when there is lack or change in the composition of the nutrients. Hence Nutrition and Human Metabolism are directly proportional and when there is an alarming signal in the proportionality level it leads to nutritional deficiencies, abnormal chemical reactions and disease in organs involving the metabolism.

Track12.Diabetes-A Common Entity

Diabetes is all approximately affront levels and sugar levels and what we put in our body. Type 2 Diabetes is the most common among the rest of the two types (Type 1 Diabetes, gestational Diabetes). The mechanism is all about the working of insulin in our body. Depositing insulin produced in our body will lead to health problems like Diabetes mellitus. A1C test, Fasting plasma glucose (FPG) test, Random plasma glucose (RPG) test,  are the clinical tests done to analyse the presence of Glucose levels in human body. Regular testing and proper diet will automatically alter the maintenance of blood sugar level.

Track13.Obesity and Metabolic Disorders

Overweight undermines the prosperity and individual fulfilment of a growing number of People. Hence national governments and the National Commission have distributed liberal advantages for find how to switch this example. Disregarding the way that we know a wonderful course of action about body weight control structures and that these are affected by genetic traits, the present rate in corpulence in every country is immensely influenced by way of life, dietary patterns and physical exercise.

Track14.Emerging Focus on Metabolic Disorders

Bioinformatics tool provide the basic capabilities to approach Metabolic Disorders in various dimensions. Bioinformatics strategies and devices are basic to analyse and translate information from microarrays. Thus, microarray investigation gives a phenomenal opportunity to encourage the understanding of the etiology and movement of liver cancer. Bariatric surgery which is an approaching remedy will also reduce the risk of Type 2 Diabetes which thereby prevents a person from any metabolic disorders and Liver Cancer.

Track15.Next Generation Ideology towards Metabolic Disorders

Next Generation Techniques approaches with genomic, epigenomic and translational molecular layers for analysis. Next Generation Sequencing(NGS) advances guarantee a worldwide see on oncogenomics by encouraging integrator and proficient discovery of hereditary and epigenetic changes in cancer at a single-base determination. Ultrasonography, Chorionic Villus Sampling (CVS), maternal blood sampling for fetal DNA, Pediatric Cataract Surgeries, Kovatchev's artificial pancreas are the most indispensable ideas that are being and soon will be an reasonable option in treating Metabolic diseases.  

Track16.Healthcare Management -An Alternative Remedy

As rightly the Proverb says “Health is Wealth’’, taking care of one’s is very important to live a disease free life which automatically gives us a wealthy life. But to consider only 10 countries in the world are considered to be healthiest countries. Even the resources are available at most places still only 10 countries have the healthiest people among  195 countries rest.  Healthcare includes prevention, diagnosis, treatment of disease, illness, injury, and other physical and mental impairments. For a healthy and wealthy life one can concentrate more on his/her health by feeding it with good thoughts, good food and exercises which relaxes one from stress and mental illness. Proper Diet and proper exercise paves way for a disease free life.

Societies related with Cancer and Metabolic Diseases:

Saudi Cancer Society, Dubai, UAE.

Saudi oncology society and Saudi urology association, Dubai, UAE.

Saudi Arabia Cancer Organizations and Resources, Dubai, UAE.

Malaysian Oncology Society, Malaysia.

Malaysian Society of Paediatric Haematology and Oncology, Malaysia.

American Association for Cancer Research, USA.

American Brain Tumor Association, USA.

American Cancer Society, USA.

American Society for Radiation Oncology, USA.

American Society of Clinical Oncology, USA.

European Association for Cancer Research, Europe.

Association for International Cancer Research AICR, UK.

Association of European Cancer Leagues, Europe.

European Oncology Nursing Society, Europe.

European Society for Medical Oncology, Europe.

European Society of Surgical Oncology, Europe.

German Society for Digestive and Metabolic Diseases,Germany.

Acoustic Neuroma Association of Australia, Australia.

Clinical Oncological Society of Australia, Australia.

Asian Society for Neuro-Oncology, Asian.

Society For Inherited Metabolic Disorders, California.

Top Universities In Dubai

               Murdoch University, Dubai

Heriot Watt University Dubai Campus

Modul University Dubai

Middlesex University Dubai

Hamdan Bin Mohammed  Smart University

Curtin University Dubai

University of South Wales Dubai

Emirates Aviation University

Institute of Metabolism and Systems Research (IMSR)

Morgridge Institute for Research

Canadian Institute of Health Research

National Institute of Environmental Health Sciences

Al Ghurair University (AGU)

University of Dubai (UD)

Zayed University

American University in Dubai (AUD)

British University in Dubai (BUID)

American University in the Emirates (AUE)


University of Chicago, Chicago

University of Toronto, Canada

Washington University in St. Louis

Thomas Jefferson University

National University of Singapore (NUS), Singapore

Indianapolis University “La Sapienza” of Rome, Rome, Italy

University of Wisconsin, Madison-

University of Tokyo, Japan

Guangxi Medical University, Nanning, China

University of Lyon, France

University Of Leeds

University Of Queensland, Australia

University of Arizona Cancer Center

University of Utah

Georgetown University Medical Center

University of Southampton

University of Pittsburgh

McMaster University

University Of Florida

Vanderbilt University School of Medicine

Wayne State University School of Medicine




Assembly Biosciences



Conatus Pharmaceuticals

Dicerna Pharmaceuticals

Enanta Pharmaceuticals




Madrigal Pharmaceuticals



Intercept Pharmaceuticals




Speciality Hospitals

Major Hospitals in Dubai

Al Zahra Private Hospital

Sheikh Khalifa Medical City

Latifa Hospital

Zulekha Hospital

Armada Hospital

Dubai Herbal Treatment Center

Al Jalila Children’s Speciality Hospital

Iranian Hospital

Rashid Hospital

Major Hospitals Worldwide

Abbott Northwestern Hospital, Minneapolis, MN  

Advocate Lutheran General Hospital, Park Ridge, IL  

Allegheny General Hospital, Pittsburgh, PA  

Baptist Hospital of Miami, Miami, FL  

Barnes-Jewish Hospital/Washington University, St. Louis, MO  

Boston Medical Center, Boston, MA  

Brigham and Women's Hospital, Boston, MA  

California Pacific Medical Center CA Campus, San Francisco, CA  

Case Western Reserve University  

Cedars-Sinai Medical Center, Los Angeles, CA  

Christiana Care, Newark, DE  

Cleveland Clinic, Cleveland, OH  

Columbia University Medical Center 

Cornell University, Weill Medical College  

Dartmouth Medical School

Related Conferences:  Cancer Treatment and Drug therapy  | Genetics and Epigenetics of Cancer  | Metabolic disorders  | Metabolic Syndrome Conferences  | Oncologists Meetings


EUROPE: Blue Faery - The Adrienne Wilson Liver Cancer Association, European Association for the Study of the Liver, Association of Community Cancer Center, Childhood Cancer Research Group, World Hepatitis Alliance, The International Liver Cancer Association, The International Diabetes Federation, Belgian Association for Metabolic Diseases, British Inherited Metabolic Disease Group, The European Association for the Study of Obesity, British Association for Community Child Health, German Society of Radiation Oncology, National Cancer Council, Radiation Therapy Oncology Group,Canadian Cancer Society

USA: American Association for the Study of Liver Diseases, American Society of Clinical Oncology, CanLiv -The Hepatobiliary Cancers Foundation, American Association for Cancer Research, Association for the Study of Lung Cancer, Canadian Association of Radiation Oncology, Society For Inherited Metabolic Disorders, American Diabetes Association, The Obesity Society, Child Health Association Of Sewickley, American Society for Blood & Marrow Transplantation

MIDDLE EAST AND ASIA PACIFIC: The Asian Pacific Association for the Study of the Liver,The Asia-Pacific Primary Liver Cancer Expert Association, The Japan Society of Hepatology, Indian Cancer Society, Association of Radiation Oncologists of India, Australian Association of Smoking Cessation Professionals, Australasian Hepatology Association, South Asian Association for the Study of the Liver, Obesity Surgery Society of India, Saudi Oncology Society, New Zealand Bone Marrow Donor Registry, Saudi Arabia Cancer Organizations and Resources, Malaysian Oncology Society

Market Analysis

           Cancer is considered to be the leading cause death globally by statistical reports and the report also obviously gives information that the low- and middle-income countries around the world are been mostly affected. Tobacco use, alcohol use, unhealthy diet, and chronic infections from hepatitis B (HBV), hepatitis C virus (HCV) and some types of Human Papilloma Virus (HPV) are leading risk factors for cancer in low- and middle-income countries. With emerging advanced technologies and researches in treating cancer there is a hope for many cancer survivors for a long time survival. There are later progressions in the cancer medications & cancer care is quickening. A bunch of inventive solutions, regularly common with other modern or existing arrangements, and routinely related with biomarkers, are rising from the imaginative work pipeline. In the course of recent years, 70 modern oncology drugs have been impelled and are being utilized to treat more than 20 assorted tumor types. Yearly around the world advancement in the oncology medicate showcase is required to be 7.5 – 10.5 % through 2020, accomplishing $150 billion. More broad utilization of modern items—particularly immunotherapies will drive awesome portion of the improvement, counteracted by reduced utilization of a few current medications with average clinical results. The perception that cancer rate is distinctive around the world, that it changes over time, and that transients from low-risk nations accomplish the hazard of counting physical, chemical, and natural components in the living and occupational environment as well as behavioural and sociocultural variables such as slim down, smoking, liquor consumption, and fertility. The prevalence of Metabolic Disease found is similar to that in developed countries, being influenced by age, body mass index, educational levels, physical activity, and leading to a higher prevalence of cardiovascular complications after the 4th decade of life.



It is estimated that almost 1.7 million new cases of cancer are been diagnosed every year and it’s been increasing year by year.. Prostate cancer is the most common cancer among males (19%), followed by lung (14%) and colorectal (9%) cancers. Among females, breast (30%), lung (12%), and colorectal (8%) cancers are the most common.


The study showed that 22.7% of the population has metabolic disorder, which increments with age, higher BMI and inactive way of life. There was no critical distinction between genders until age ≥70 a long time and social classes. Damage to genes may be due to internal factors, such as hormones or the metabolism of nutrients within cells, or external factors, such as tobacco, chemicals, and sunlight. It is estimated that 5%-10% of all metabolic diseases are strongly hereditary, meaning that individuals who inherit a specific genetic alteration have a very high risk of developing a particular disorder. It is thought that many metabolic disorders result from a combination of hereditary and environmental factors.



                                    ‘Cancer is the third leading cause of death in Emirate'

      13% of total death is caused by cancer in UAE. 1500 new patients are received annually at the speciality hospitals in Emirates. From the reports of Oncology Conference in UAE, the lifestyle of people over the place is greatly affecting their health and metabolism which is leading cancer as a genetic inherited disorder. Dr. Nobert Dreier an oncologist from the Al- Zahira cancer speciality hospital reported that cancer will be a number one killer disease beating cardiovascular disease within 20 years.

Past Conference Report


Metabaolic Syndrome 2016 Reports

The International Conference on Metabolic Syndromes (Metabolic Syndrome 2016) conducted by  Conference Series during October 17-18, 2016 was successfully held at Holiday Inn Rome Aurelia, Rome, Italy with a theme “Advancements in Metabolic disorder diagnostics and newer treatment strategies for prevention cure” was a great success where eminent keynote speakers from various reputed institutions with their resplendent presence addressed the gathering.

Thanks to all our momentous speakers, conference attendees who contributed towards the successful run of the conference. Metabolic Syndrome 2016 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various new-fangled topics related to the fields of Endocrinology, Diabetes, Pediatrics, and obesity.

The meeting was carried out through various sessions, in which the discussions were held on the following major scientific tracks:

  • Metabolic Syndrome
  • Cardiovascular Disorders
  • Oxidative Stress, Inflammation and Angiogenesis in the Metabolic Syndromes
  • Obesity, Diabetes and Metabolism
  • Endocrine Disorders
  • Insulin Resistant Syndrome
  • Nutrition and Metabolic Responses

Metabolic Syndrome 2016 Organizing Committee would like to thank the Moderator of the conference, Dr.Nihal El Habachi, Alexandria University School of Medicine, Egypt who has contributed a lot for the smooth functioning of this event.

Metabolic Syndrome 2016 extends its warm gratitude to all the Honourable Guest and Keynote Speakers of the event:

  • Dr. Arie Franx, University Medical Centre Utrecht, Netherlands
  • Dr. Arturo Solis Herrera, Human Photosynthesis, Mexico
  • Dr. Kang Choon Lee, SungKyunKwan University, South Korea

Conference Series is privileged to felicitate Metabolic Syndrome 2016 Organizing Committee, Chairs & Co-Chairs who supported for the success of this event. Conference Series would like to thank every individual participant for the enormous exquisite response. This inspires us to continue organizing events and conferences for further research in the field of Human Metabolism.With the valuable feedback received from the participants of Metabolic Syndrome 2016, Conference Series is glad to announce the commencement of “International Metabolic Diseases and Liver Cancer Conference during September 17-18, 2018 Dubai, UAE. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of and Metabolic Diseases and Liver Cancer.

To Collaborate Scientific Professionals around the World

Conference Date May 27-28, 2019

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

Journal of Liver Journal of Endocrinology & Metabolic Syndrome Journal of Metabolic Syndrome Journal of Diabetes & MetabolismJournal of Diabetes & Metabolism

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner




Media Partner




  • Ablation
  • Abnormal Chemical Recations
  • Adipose Tissue Transplantation
  • Aflatoxin
  • Alcohol Abuse
  • American Syndrome
  • Autopsy
  • Autosomal Recessive
  • Bariatric Surgery
  • Bioinformatics
  • Bioinformatics And Genomic Technology
  • Biomarker
  • Biopsy
  • Bone Marrow Transplant
  • Cancer Immunotherapy
  • Cancer Treatment
  • Cardiovascular Disease
  • Central Obesity
  • Chemoembolization
  • Chemotherapy
  • Cirrhosis
  • Clinical Epigenetics And Biomarkers
  • Clinical Genetics
  • Computerized Tomography
  • Diabetes
  • DNA Methylation
  • DNA Testing
  • Drug Discovery
  • Emerging Focus In Diabetes Research
  • Epidemiology Of Metabolic Syndrome
  • Epigenetics And Metabolism
  • Gene Control By Metabolism
  • Gene Mutation
  • Gene Therapy
  • Genetic Counselling
  • Hemochromatosis
  • Hepatitis B
  • Hepatitis C
  • Hepatocellular Carcinoma
  • Hepatoma
  • High Blood Pressure
  • Human Genetics
  • Human Health
  • Human Immunodeficiency
  • Human Physiology
  • Immunity Related Disorders
  • Immunosuppression
  • Inborn Error Of Metabolism
  • Insulin Resistance
  • Interferon
  • Internal Radiation Therapy
  • Intrahepatic
  • Laparoscopy
  • Lifestyle Changes
  • Liver Cancer
  • Magnetic Resonance Imaging
  • Medical Research
  • Metabolic Pathway
  • Metastasis
  • Methylation
  • Molecular Biology
  • Molecular Diagnostics
  • Molecular Genetics
  • Nausea
  • Night Sweats
  • Nutrition
  • Nutrition And Cancer
  • Nutrition Transition
  • Obesity
  • Obesity And Oncology
  • Paediatric Diabetes
  • Pediatric Oncologist
  • Phenotypic Heterogeneity
  • Polycystic Ovarian Syndrome
  • Prognosis
  • Psychiatric Illnesses
  • Quality Of Life
  • Radiation
  • Radiation Therapy
  • Radioactive
  • Radiofrequency Ablation
  • Radiologic
  • Regenerative Biology And Stem Cell Research
  • Role Of Anaesthesiologists In Obesity
  • Screening
  • Sedentary Lifestyle
  • Statistical Analysis
  • Statistical Genetics
  • Stem Cell Transplant
  • Stem Cells And Regenerative Medicine
  • Stereotactic
  • Stomach
  • Surgery
  • Systemic
  • Systemic Therapy
  • Targeted Drug Delivery
  • Targeted Therapy
  • Transplantation
  • Tumor Necrosis Factor
  • Tumor Necrosis Factor
  • Type 2 Diabetes
  • Urbanization